WASHINGTON, D.C. — Sens. Orrin G. Hatch and Michael Bennet reintroduced legislation Friday to create a new drug approval pathway to streamline access and encourage innovation and development of potentially lifesaving antibiotic drugs for patients, particularly veterans who have encountered antibiotic-resistant bacteria while overseas.
America has always been a beacon for innovation and discovery. The PATH Act will allow health experts to more easily develop new treatments for antibiotic-resistant bacteria, and make real progress in preventing a great number of illnesses and deaths in the United States. I was pleased our proposal ...
Also read: PDF Document Scanner App